feed,title,long_url,short_url
Benzinga,AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer,https://benzinga.com/general/biotech/24/03/37785767/astrazeneca-says-lynparzaimfinzi-combo-shows-strong-clinical-benefit-vs-chemotherapy-in-endometri,https://da.gd/pHhCGU
